Potassium, magnesium, and electrolyte imbalance and complications in disease management

被引:30
作者
Weglicki, W
Quamme, G
Tucker, K
Haigney, M
Resnick, L
机构
[1] George Washington Univ, Med Ctr, Washington, DC 20052 USA
[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[3] Tufts Univ, Medford, MA 02155 USA
[4] Uniform Serv Univ, Bethesda, MD USA
[5] Cornell Univ, Weill Med Sch, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
congestive heart failure; diabetes; diuretic complications; hypertension; magnesium; potassium;
D O I
10.1081/CEH-200044275
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Electrolyte balance is a critical issue in managing comorbid conditions in both diseased and elderly patients. Patients with hypertension and diabetes need careful regulation of their calcium and magnesium levels, whereas in patients with congestive heart failure, sodium and potassium levels also are critical. Herein we report the outcome of a round table discussion at which issues of renal magnesium clearance, magnesium and arrhythmic risk, ion balance in heart failure, diabetes, ischemic stress, oxidative stress in the cardiomyopathy of magnesium deficiency, roles of magnesium and potassium in bone metabolism and the aging population, and the role of electrolyte balance in hypertension have been discussed. In all these issues the maintaining homeostasis of potassium and magnesium is critical and the various therapies that impact on retaining these ions were discussed. Hallmark studies, i.e., Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial and Studies of Left Ventricular Dysfunction, have provided insight into treatment of patients with cardiovascular and progressive heart failure. These studies and the availability of potassium- and magnesium-sparing diuretics for use in these disorders provide relevant perspectives for treatment.
引用
收藏
页码:95 / 112
页数:18
相关论文
共 68 条
[41]   LOSS OF RED-BLOOD-CELL GLUTATHIONE DURING MG DEFICIENCY - PREVENTION BY VITAMIN-E, D-PROPRANOLOL, AND CHLOROQUINE [J].
MAK, IT ;
STAFFORD, R ;
WEGLICKI, WB .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1994, 267 (05) :C1366-C1370
[42]  
Moore Tera D, 2003, Heart Dis, V5, P354, DOI 10.1097/01.hdx.0000089783.30450.cb
[43]   MODULATION OF ELECTROLYTE EXCRETION BY POTASSIUM RETAINING DIURETICS [J].
NETZER, T ;
KNAUF, H ;
MUTSCHLER, E .
EUROPEAN HEART JOURNAL, 1992, 13 :22-27
[44]   INTERACTION OF DIURETICS AND ELECTROLYTES IN CONGESTIVE HEART-FAILURE [J].
NICHOLLS, MG .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (10) :E17-E21
[45]   NEURO-HORMONAL INTERACTIONS AND ADAPTATIONS IN CONGESTIVE HEART-FAILURE [J].
PACKER, M .
CIRCULATION, 1988, 77 (04) :721-730
[46]   The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].
Pitt, B ;
Zannad, F ;
Remme, WJ ;
Cody, R ;
Castaigne, A ;
Perez, A ;
Palensky, J ;
Wittes, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717
[47]   Arrhythmogenesis and contractile dysfunction in heart failure -: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual β-adrenergic responsiveness [J].
Pogwizd, SM ;
Schlotthauer, K ;
Li, L ;
Yuan, WL ;
Bers, DM .
CIRCULATION RESEARCH, 2001, 88 (11) :1159-1167
[48]   Diuretics and the therapy of hypertension [J].
Puschett, JB .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2000, 319 (01) :1-9
[49]   CELLULAR IONS IN HYPERTENSION, DIABETES, AND OBESITY - A NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPIC STUDY [J].
RESNICK, LM ;
GUPTA, RK ;
BHARGAVA, KK ;
GRUENSPAN, H ;
ALDERMAN, MH ;
LARAGH, JH .
HYPERTENSION, 1991, 17 (06) :951-957
[50]   Relation of cellular potassium to other mineral ions in hypertension and diabetes [J].
Resnick, LM ;
Barbagallo, M ;
Dominguez, LJ ;
Veniero, JM ;
Nicholson, JP ;
Gupta, RK .
HYPERTENSION, 2001, 38 (03) :709-712